|
0
|
|
Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South.
(academic.oup.com)
|
Colasanti JA
…
Collins LF
Clinical Infectious Diseases
2026-04-30
|
#amr
#viremia
#treatment
#hiv
|
|
0
|
|
Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States.
(academic.oup.com)
|
Nambiar PH
…
Durand CM
Clinical Infectious Diseases
2026-04-30
|
#infection
#transplantation
#serology
#hiv
#kshv
|
|
0
|
|
Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.
(academic.oup.com)
|
Appa A
…
Gandhi M
Clinical Infectious Diseases
2026-04-30
|
#viremia
#treatment
#hiv
#addiction
#implementation
|
|
0
|
|
Hepatitis B Reactivation in a US Cohort of People With HIV and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
(academic.oup.com)
|
Denyer RV
…
Weintrob A
Clinical Infectious Diseases
2026-04-30
|
#hiv
#hepatitis b
#reactivation
#co-infection
|
|
0
|
|
Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial.
(academic.oup.com)
|
Obeng BM
…
Kelleher AD
Clinical Infectious Diseases
2026-04-30
|
#amr
#phylogenomics
#sequencing
#mutation
#hiv
|
|
0
|
|
In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.
(academic.oup.com)
|
Mann SC
…
MaWhinney S
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#viremia
#hiv
#adherence
|
|
0
|
|
Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.
(academic.oup.com)
|
Osuala EC
…
Naidoo A
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#hiv
#drug-drug interaction
#tb
|
|
0
|
|
Immunogenicity and Safety of 2 Versus 3 Doses of 9-Valent Vaccine Against Human Papillomavirus in Women With Human Immunodeficiency Virus: The Papillon Randomized Trial.
(academic.oup.com)
|
Konopnicki D
…
De Wit S
Clinical Infectious Diseases
2026-04-30
|
#vaccination
#immunogenicity
#hiv
#immunocompromised
#seroconversion
|
|
0
|
|
Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection.
(academic.oup.com)
|
Martinez-Martin P
…
Arribas JR
Clinical Infectious Diseases
2026-04-30
|
#aging
#epigenetics
#hiv
#biomarker
#prognosis
|
|
0
|
|
Changing Clinical and Laboratory Characteristics of Progressive Multifocal Leukoencephalopathy: A Retrospective National Cohort Study.
(academic.oup.com)
|
Mainardi I
…
Cinque P
Clinical Infectious Diseases
2026-04-30
|
#infection
#hiv
#immunocompromised
#neurological
#survival
|
|
0
|
|
The Potential Effect of Ending Centers for Disease Control and Prevention Funding for HIV Tests: A Modeling Study in 18 States.
(academic.oup.com)
|
Balasubramanian R
…
Fojo AT
Clinical Infectious Diseases
2026-04-30
|
#modeling
#screening
#transmission
#hiv
|
|
0
|
|
Human Papillomavirus-Related Anal Precancerous Lesions in Men Who Have Sex With Men: A Comparative Study of Pre-exposure Prophylaxis Users and HIV-Positive Individuals.
(academic.oup.com)
|
Surmont M
…
Kindt S
Clinical Infectious Diseases
2026-04-30
|
#infection
#cancer
#hiv
#hpv
#pathology
|
|
0
|
|
Impact of Vaginal Estradiol on the Genitourinary Syndrome of Menopause, Vaginal Microbiome and Mucosal Immune Mediators in Women With HIV.
(academic.oup.com)
|
Murphy K
…
Herold BC
Clinical Infectious Diseases
2026-04-30
|
#microbiome
#immunity
#hiv
#menopause
#estrogen
|
|
0
|
|
LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.
(academic.oup.com)
|
Okumura N
…
Ujiie M
Clinical Infectious Diseases
2026-04-30
|
#vaccination
#prophylaxis
#immunogenicity
#hiv
#mpox
|